Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19 : a randomized clinical trial
Izdano u: | Nature Cancer 4(2023)1, S. 96-107 |
---|---|
Glavni autori: | Denkinger, Claudia M. (Autor), Janssen, Maike (Autor), Pohle, Thorsten (Autor), Ruhe, Matthias (Autor) |
Format: | Članak |
Jezik: | English |
Izdano: |
2023
|
Teme: | |
Online pristup: | https://doi.org/10.1038/s43018-022-00503-w |
Povezana djela: | In:
Nature Cancer |
Similar Items
-
Phenobarbitalintoxikation in suizidaler Absicht : kontinuierliche venovenöse Hämodialyse als effektive Therapie
od: Ruhe, Matthias, i dr.
Izdano: (2016) -
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders : a cohort study from Germany
od: Kümpfel, Tania, i dr.
Izdano: (2020) -
Impact of physical or sexual childhood abuse on plasma DHEA, DHEA-S and cortisol in a low-dose dexamethasone suppression test and on cardiovascular risk parameters in adult patients with major depression or anxiety disorders
od: Kellner, Michael, i dr.
Izdano: (2018) -
Transiente globale Amnesie und Tako-Tsubo-Kardiomyopathie - Zufall oder logische Folge?
od: Grautoff, Steffen, i dr.
Izdano: (2012) -
Effects of 35% carbon dioxide (CO 2) inhalation in patients with post-traumatic stress disorder (PTSD) : a double-blind, randomized, placebo-controlled, cross-over trial
od: Kellner, Michael, i dr.
Izdano: (2018)